Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2413-2422
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2413
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2413
Figure 1 Liver function indices before and after surgery.
A: Alanine aminotransferase; B: Aspartate aminotransferase; C: Total bilirubin; D: Direct bilirubin concentrations before (orange) and after (green) surgery. aP < 0.05; bP < 0.01; dP < 0.0001. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; DBIL: Direct bilirubin.
Figure 2 Renal function markers before and after surgery.
A: Creatinine; B: Blood urea nitrogen concentrations before (orange) and after (green) surgery. cP < 0.001, dP < 0.0001. Cr: Creatinine; BUN: Blood urea nitrogen.
Figure 3 Three-year survival curves of independent prognostic factors.
A: Overall survival; B: Tumor stage; C: Distant metastasis; D: Treatment plan. HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Wu JX, Hua R, Luo XJ, Xie F, Yao L. Effects of cytoreductive surgery combined with hyperthermic perfusion chemotherapy on prognosis of patients with advanced gallbladder cancer. World J Gastrointest Surg 2023; 15(11): 2413-2422
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2413.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2413